1. Home
  2. FRES vs RVYL Comparison

FRES vs RVYL Comparison

Compare FRES & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRES
  • RVYL
  • Stock Information
  • Founded
  • FRES 2010
  • RVYL 2007
  • Country
  • FRES United States
  • RVYL United States
  • Employees
  • FRES N/A
  • RVYL N/A
  • Industry
  • FRES Medical Specialities
  • RVYL Professional Services
  • Sector
  • FRES Health Care
  • RVYL Consumer Discretionary
  • Exchange
  • FRES Nasdaq
  • RVYL Nasdaq
  • Market Cap
  • FRES 70.9M
  • RVYL 13.7M
  • IPO Year
  • FRES 2020
  • RVYL N/A
  • Fundamental
  • Price
  • FRES $2.65
  • RVYL $2.02
  • Analyst Decision
  • FRES
  • RVYL Hold
  • Analyst Count
  • FRES 0
  • RVYL 1
  • Target Price
  • FRES N/A
  • RVYL N/A
  • AVG Volume (30 Days)
  • FRES 10.5K
  • RVYL 46.0K
  • Earning Date
  • FRES 07-30-2024
  • RVYL 08-12-2024
  • Dividend Yield
  • FRES N/A
  • RVYL N/A
  • EPS Growth
  • FRES N/A
  • RVYL N/A
  • EPS
  • FRES N/A
  • RVYL N/A
  • Revenue
  • FRES $2,345,304.00
  • RVYL $71,352,000.00
  • Revenue This Year
  • FRES N/A
  • RVYL $31.47
  • Revenue Next Year
  • FRES N/A
  • RVYL N/A
  • P/E Ratio
  • FRES N/A
  • RVYL N/A
  • Revenue Growth
  • FRES N/A
  • RVYL 78.42
  • 52 Week Low
  • FRES $2.50
  • RVYL $1.12
  • 52 Week High
  • FRES $41.80
  • RVYL $17.50
  • Technical
  • Relative Strength Index (RSI)
  • FRES 35.87
  • RVYL 59.40
  • Support Level
  • FRES $2.50
  • RVYL $1.95
  • Resistance Level
  • FRES $3.40
  • RVYL $2.25
  • Average True Range (ATR)
  • FRES 0.41
  • RVYL 0.21
  • MACD
  • FRES -0.03
  • RVYL 0.05
  • Stochastic Oscillator
  • FRES 11.81
  • RVYL 63.11

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

Share on Social Networks: